SCHOTT Pharma AG & Co. KGaA (FRA:1SXP)

Market Cap	3.68B
Revenue (ttm)	954.68M
Net Income (ttm)	134.17M
Shares Out	n/a
EPS (ttm)	0.89
PE Ratio	27.44
Forward PE	n/a
Dividend	0.16 (0.64%)
Ex-Dividend Date	Feb 5, 2025

Volume	23,773
Average Volume	86,133
Open	24.70
Previous Close	24.44
Day's Range	24.44 - 25.54
52-Week Range	22.22 - 42.20
Beta	n/a
RSI	53.20
Earnings Date	Feb 13, 2025

About FRA:1SXP

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharmaceutical, biotechnology, and life science industries worldwide. The company offers prefillable glass or polymer syringes, glass vials, cartridges, and ampoules. Its syringe products include syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPA...

• Industry: Glass Containers
• Founded: 1884
• Employees: 4,690
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 1SXP

Financial Performance

In 2024, FRA:1SXP's revenue was 957.09 million, an increase of 6.51% compared to the previous year's 898.60 million. Earnings were 149.69 million, a decrease of -1.42%.